---
figid: PMC9223605__ijms-23-06689-g001
pmcid: PMC9223605
image_filename: ijms-23-06689-g001.jpg
figure_link: /pmc/articles/PMC9223605/figure/ijms-23-06689-f001/
number: Figure 1
figure_title: ''
caption: Molecular pathway depicting TGF-β-induced cutaneous fibrosis. The small-molecule
  inhibitor galunisertib prevents the phosphorylation of the intracellular domain
  on the TGF-βR-1/ALK5 serine-threonine kinase, thereby preventing downstream Smad2/3
  signaling and nuclear translocation, resulting in the attenuation of fibrotic phenotypes.
article_title: Galunisertib Exerts Antifibrotic Effects on TGF-β-Induced Fibroproliferative
  Dermal Fibroblasts.
citation: Joshua M. Peterson, et al. Int J Mol Sci. 2022 Jun;23(12):6689.
year: '2022'

doi: 10.3390/ijms23126689
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- fibrosis
- TGF- β inhibition
- myofibroblast
- ALK5
- injury

---
